Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.32 |
| ▸ | DRD1 | P21728 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25753217 | 0.74 | GAA (0.49) | GAAALDH1A1NPC1KMT2ACYP4F2 | |
| SCHEMBL25753201 | 0.74 | SCN2A (0.44) | SCN2AALDH1A1MAPTNPC1KMT2A | |
| SCHEMBL25753161 | 0.73 | SCN2A (0.43) | SCN2AALDH1A1MEN1NPC1S1PR4 | |
| SCHEMBL25753210 | 0.68 | SCN2A (0.39) | SCN2AALDH1A1MAPTKMT2ALMNA | |
| SCHEMBL20640604 | 0.68 | GAA (0.44) | GAACYP1A2CYP2C19ALDH1A1MAPT | |
| SCHEMBL31106066 | 0.68 | GAA (0.39) | GAAALDH1A1MAPTKMT2ACYP4F2 | |
| SCHEMBL31510959 | 0.68 | CYP1A2 (0.38) | CYP1A2CYP2C9CYP2C19ALDH1A1MAPT | |
| SCHEMBL30134356 | 0.67 | MAPT (0.39) | GAAALDH1A1MAPTLMNATSHR | |
| SCHEMBL29258348 | 0.67 | L3MBTL1 (0.37) | GAAALDH1A1MAPTMEN1NPC1 | |
| SCHEMBL31106124 | 0.66 | GAA (0.38) | GAACYP1A2CYP2C19ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113620949-B | Synthesis method of antitumor compound and intermediate thereof | 药捷安康(南京)科技股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| US-20230212167-A1 | METHOD FOR SYNTHESIZING ANTI-TUMOR COMPOUND AND INTERMEDIATES THEREOF | TRANSTHERA SCIENCES (NANJING), INC. (CN) | 2023-07-06 | — | — | US | disclosed |
| US-20230212167-A1 | METHOD FOR SYNTHESIZING ANTI-TUMOR COMPOUND AND INTERMEDIATES THEREOF | TRANSTHERA SCIENCES (NANJING), INC. (CN) | 2023-07-06 | — | — | US | disclosed |
| CN-113620949-A | Synthesis method of antitumor compound and intermediate thereof | 南京药捷安康生物科技有限公司 | 2021-11-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212167-A1 | METHOD FOR SYNTHESIZING ANTI-TUMOR COMPOUND AND INTERMEDIATES THEREOF | SQLE, HCCS, DHPS | GAA 339/4885SCN2A 4538/4885CYP1A2 485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.